B&R Therapy and the Gut
The "Post-Induction Gap": Why the Weeks After B&R Therapy Matter for Your Heart and Gut A Gemini deep research report If you or a loved one has recently finished six cycles of Bendamustine-Rituximab (B&R) for Follicular Lymphoma, you know the feeling: relief. The infusions are done, the port is de-accessed (or at least resting), and you are likely in that 4-to-8-week waiting period before your final scan and potential maintenance therapy. Clinicians call this the "Post-Induction Gap." It’s often viewed as a quiet time for recovery. But new research suggests that physiologically, this is actually a very dynamic window—especially for your gut and your cardiovascular system. Here is a breakdown of what is actually happening in your body during these quiet weeks, based on recent synthesis of pharmacological and microbiome science. 1. The Chemical Mismatch: One Drug Leaves, The Other Stays The B&R regimen combines two very different types of drugs, and they...